Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Terrafame to bring its battery chemicals plant to a halt due to the national strikes in Finland

Terrafame has decided to bring the company’s battery chemicals plant to a halt for approximately four weeks. The shutdown is a result of the industrial actions in Finland that have continued for several weeks and are affecting the logistics chain. Due to the strikes, Terrafame has not been able to execute the export deliveries of the products of its battery chemicals plant, which has forced Terrafame to store the products in its industrial area. The possibilities for storing said products in the industrial area are limited due to, for example, restricted storage capacity and challenges in

Terrafame concluded its change negotiations

In February 2024, Terrafame announced that it had decided to initiate a profitability programme, aiming to generate EUR 10 million in annual savings and to improve the company’s international competitiveness and profitability. As part of the profitability programme, Terrafame issued on 21 February 2024 an invitation to change negotiations concerning all personnel groups on production-related and financial grounds in accordance with the Finnish Co-operation Act. The negotiations affected Terrafame’s entire personnel, which is comprised of over 800 permanent employees. The aim of the

Aker ASA – Successful Bond Issue

Aker ASA has today successfully issued NOK 300 million in a 7-year senior unsecured bond with a coupon of 3 months Nibor + 1.80% per annum. An application will be made for the bond to be listed at the Oslo Stock Exchange. Nordea acted as Sole Arranger for the bond issuance. -ENDS- Investor contact:Fredrik Berge, Head of Investor Relations Aker ASATel: +47 450 32 090E-mail: fredrik.berge@akerasa.com This information is subject to the disclosure requirements pursuant to section 5 -12 the Norwegian Securities Trading Act.

Notice to the Annual General Meeting in Lindab International AB (publ)

The shareholders of Lindab International AB (publ) (the “Company” or “Lindab”) are hereby invited to attend the Annual General Meeting to be held at 3 pm (CEST) on Tuesday May 14, 2024, at Lindab Experience Center in Grevie.Registration for the Annual General Meeting begins at 2 pm. The Board has resolved that the shareholders will be able to exercise their voting rights by postal voting in accordance with Chapter 7, Section 4a of the Swedish Companies Act (2005:551) and the Company’s articles of association. Shareholders may therefore choose to exercise their voting rights at the Annual

Notice of annual general meeting in AB Sagax (publ)

The shareholders of AB Sagax (publ), 556520-0028, (the ” Company”) are hereby invited to the Annual General Meeting (“AGM”) to be held on Wednesday 8 May 2024 at 4.00 p.m. at Spårvagnshallarna, Birger Jarlsgatan 57A in Stockholm. The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to § 9 in the Company’s Articles of Association. Consequently, shareholders may choose to exercise their voting rights at the AGM by attending by postal voting, in person, or through a proxy. Participation by

Reporting from Dicot's phase 1 study end of April

Press release: Uppsala, April 5, 2024. Yesterday, Dicot completed the clinical phase of the second and final part of its phase 1 study. The company can thus confirm that the reporting from this part of the study will be published at the end of April, followed by an in-depth summary of results for the entire phase 1 study later in the second quarter.Dicot's Phase 1 study of the potency drug candidate LIB-01 is placebo-controlled and double-blind with the primary objective to investigate the safety profile in humans. It started in August last year and consists of two parts: single doses (SAD)

Mandatum has published its Annual Report 2023

Mandatum plc, Stock exchange release, 5 April 2024 at 9:30 a.m. EEST   Mandatum has today published its Annual Report for 2023 on the company’s website www.mandatum.fi/en/year2023. The Annual Report contains a business and strategy review, Capital Management report, Report of the Board of Directors, and the audited Financial Statements. Also, the Sustainability Report, the Corporate Governance Statement and the Remuneration Report for Governing Bodies have been published as part of Mandatum’s annual reporting for 2023. The reports are available in both Finnish and English.   The

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS05 April 2024 at 09:30NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: BINGAB Barents Investment Group ABPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive OfficerIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 57472/5/6 ____________________________________________Transaction date: 2024-04-02

Oneflow’s monthly ARR update: March 2024

Press release5 April 2024 Oneflow publishes its preliminary monthly ARR. Oneflow had a total ARR (Annual Recurring Revenue) of MSEK 140.6 by the end of March 2024. This is a preliminary number. All financial reports and presentations are available for download on our website here: https://oneflow.com/ir/investors/financial-reports/ For further information, please contact: Anders Hamnes, CEO and FounderMobile: +46 76 788 50 76Email: anders.hamnes@oneflow.com Certified Adviser is FNCA Sweden AB. About Oneflow Oneflow develops a contract automation platform

Nurminen Logistics Plc corrects incorrect and misleading information spread in the media

Nurminen Logistics Plc                   Stock exchange release 5 April 2024 at 09.00 am  Nurminen Logistics publishes this stock exchange release regarding recent incorrect and misleading information circulating in the media. This release ensures that the market and investors have correct and up-to-date information about our company's operations and situation. We want to clarify and refute any misunderstandings or misinformation that may affect market or investor perceptions of our company. Nurminen Logistics' subsidiary, North Rail Oy, holds the railway license in Finland and

Odfjell SE: Notice of Annual General Meeting 2024

Shareholders in Odfjell SE are invited to attend the Annual General Meeting to be held online at 16:00 CET on Tuesday May 7, 2024.Shareholders must log in and cast their votes electronically. If a shareholder wishes to participate, but not vote in the meeting, a proxy or advance vote may be given.The deadline for electronic registration of advance votes, proxy of and instructions is May 5, 2024, at 16:00 CET. See registration form for guidance.The notice and guidance for digital attendance are enclosed. The following documents are available on Odfjell.com :

Invitation to presentation of Hexagon's Interim Report on 26 April

Hexagon will release its Interim Report for the first quarter 2024 on Friday, 26 April, at approximately 08:00 CET. President and CEO Paolo Guglielmini will host a live webcast and telephone conference at 10:00 CET. Webcast: The webcast will be streamed here . Telephone conference: Anyone interested in participating in the Q&A session following the first quarter Interim Report presentation must register here . 1. Upon registering, each participant will be

Corem considers issuance of green SEK senior unsecured bonds

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Imfinzi improved OS & PFS in limited-stage SCLC

05 April 2024 Imfinzi significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial Positive high-level results of the ADRIATIC Phase III trial showed AstraZeneca's Imfinzi (durvalumab) demonstrated a statistically significant and clinically meaningful improvement in the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) in patients with limited-stage small

Finnair Traffic Performance in March 2024

Finnair Plc                 Investor News              5 April 2024 at 9:00 a.m. EEST Year-on-year, passenger traffic figures declined but cargo figures improved In March, Finnair carried 918,900 passengers. This was 3.6% less than in March 2023. The overall capacity, measured in Available Seat Kilometres (ASK), increased in March by 3.9% year-on-year. If wet lease outs are included, capacity increased by 2.8%. Finnair's traffic, measured in Revenue Passenger Kilometres (RPKs), increased by 0.3%. The Passenger Load Factor (PLF) declined by 2.7% points to 75.0%. The distance-based

Safello Group AB Publishes Annual Report for 2023

Stockholm, 5 April 2024 | Today, Safello Group AB (“Safello”) publishes the company’s annual report for 2023. The annual report is available in Swedish, with an English translation, on the company’s website: safello.com/ir . “In many ways, 2023 has been one of the most eventful years in Safello's history, with a focus on strengthening the company's operational resilience and financial infrastructure. Throughout the year, the implementation of several payment methods took place, and a comprehensive bank migration to a new Swedish bank occurred.

Invitation to presentation of Sedana Medical’s interim report for the first quarter 2024

Sedana Medical AB (publ) plans to present its interim report for the first quarter of 2024 on Thursday April 25 at 13:30 CET.According to the financial calendar, Sedana Medical plans to publish the interim report for the first quarter 2024 on Thursday April 25 at approximately 07.00 CET. Sedana Medical hereby invites to a presentation of the report on the same day, where the CEO Johannes Doll will present the report in English together with Johan Spetz, CFO, and Peter Sackey, CMO, as well as answer questions. Date: Thursday, April 25, 2024 Time (CET): 13:30 More info and link to

Notice of Annual General Meeting in Karnov Group AB (publ)

The shareholders of Karnov Group AB (publ), reg. no. 559016-9016 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held at 10.00 a.m., on Wednesday 8 May 2024, at Cirio Advokatbyrå, Biblioteksgatan 9, in Stockholm. The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to Chapter 7, Section 4 a of the Swedish Companies Act and § 13 in the Company’s Articles of Associations. Therefore, shareholders may choose to exercise their voting rights at the AGM by attending by

Development update: Autogun Heroes proceeds to live phase

Supersonic is starting the publishing activities now after the launch phase and game transfer have been completed.Nitro Games announced that it has completed the launch phase of Autogun Heroes and has greenlighted the game to the live phase. The game has now been transferred to publisher Supersonic in the app stores to allow Supersonic to take over the publishing activities for the game. “We were happy with the continuous improvements we saw in the launch phase as a result of several game updates. We plan to continue that as we now proceed to the live phase. At the same time, we are now

The exercise period for Prostatype Genomic’s warrants of series 3 begins today

The exercise period for the warrants of series 3 (the "Warrants" or “TO3”) issued in connection with Prostatype Genomic AB ("Prostatype Genomics" or the "Company") rights issue of units announced on November 7, 2023 (the "Rights Issue") begins today and runs up to, and including, April 19, 2024. The exercise price is set at SEK 0.04 per share. Each Warrant entitles the holder to subscribe for one new share in Prostatype Genomics, and upon full exercise of the Warrants, the Company will receive approximately SEK 10.0 million before deductions for issuing costs.“From today you can exercise

SRV will implement the Kirkkonummi shared campus as a lifecycle project – upper secondary schools and other educational institutions under one roof in 2027

SRV GROUP PLC     INVESTOR NEWS    5 APRIL 2024  9:00 EEST SRV will implement the Kirkkonummi shared campus as a lifecycle project – upper secondary schools and other educational institutions under one roof in 2027 SRV and the municipality of Kirkkonummi have signed an agreement to implement a shared campus under a lifecycle model in Kirkkonummi. The total value of the agreement for SRV, including lifecycle services, is approximately EUR 47 million. This order is recognised in the order backlog in April. It further bolsters SRV’s order backlog, which exceeded one billion euros at the

Invitation to presentation of EQT AB’s Q1 Announcement 2024

EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.The presentation and a video link for the webcast will be available here  from the time of the publication of the Q1 Announcement. To participate by phone and ask questions during the Q&A, please register here  in advance. Upon registration, you will receive your personal dial-in

There are no items matching the current filter
There are no more items matching the current filter
Back to top